AU9139091A - Oral administration of alpha interferon to treat lung malignancies - Google Patents

Oral administration of alpha interferon to treat lung malignancies

Info

Publication number
AU9139091A
AU9139091A AU91390/91A AU9139091A AU9139091A AU 9139091 A AU9139091 A AU 9139091A AU 91390/91 A AU91390/91 A AU 91390/91A AU 9139091 A AU9139091 A AU 9139091A AU 9139091 A AU9139091 A AU 9139091A
Authority
AU
Australia
Prior art keywords
oral administration
alpha interferon
treat lung
lung malignancies
malignancies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91390/91A
Other languages
English (en)
Inventor
Francis M Cuss
Robert J Spiegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU9139091A publication Critical patent/AU9139091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU91390/91A 1990-12-14 1991-12-11 Oral administration of alpha interferon to treat lung malignancies Abandoned AU9139091A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62824090A 1990-12-14 1990-12-14
US628240 1990-12-14

Publications (1)

Publication Number Publication Date
AU9139091A true AU9139091A (en) 1992-07-08

Family

ID=24518070

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91390/91A Abandoned AU9139091A (en) 1990-12-14 1991-12-11 Oral administration of alpha interferon to treat lung malignancies

Country Status (11)

Country Link
EP (1) EP0563177A1 (et)
JP (1) JPH06503570A (et)
AU (1) AU9139091A (et)
CA (1) CA2098393A1 (et)
EE (1) EE9400337A (et)
IE (1) IE914326A1 (et)
IL (1) IL100332A0 (et)
MX (1) MX9102512A (et)
PT (1) PT99784A (et)
WO (1) WO1992010207A1 (et)
ZA (1) ZA919769B (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
ES2161793T3 (es) * 1994-04-09 2001-12-16 Hoffmann La Roche Proceso para la produccion de alfa-interferona.
US6207145B1 (en) 1997-05-09 2001-03-27 Pharma Pacific Pty Ltd. Therapeutic applications of high dose interferon
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
CN1151840C (zh) * 1996-05-09 2004-06-02 太平洋制药控股公司 干扰素在制备用于治疗哺乳动物肿瘤病的药剂中的应用
JP3806445B2 (ja) 1996-05-09 2006-08-09 ファーマ・パシフィック・プロプライエタリー・リミテッド 治療方法
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
AU2002330801A1 (en) * 2002-06-20 2004-01-06 Igor Anatolievich Pomytkin Method for oral transmucosal delivery of interferon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
EP0372809B1 (en) * 1988-12-01 1993-08-04 Schering Corporation Medicament for the treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
EP0563177A1 (en) 1993-10-06
ZA919769B (en) 1992-09-30
MX9102512A (es) 1992-06-01
IE914326A1 (en) 1992-06-17
IL100332A0 (en) 1992-09-06
CA2098393A1 (en) 1992-06-15
PT99784A (pt) 1992-12-31
WO1992010207A1 (en) 1992-06-25
EE9400337A (et) 1996-02-15
JPH06503570A (ja) 1994-04-21

Similar Documents

Publication Publication Date Title
AU5046693A (en) Use of purified surface modifiers to prevent particle aggregation during sterilization
AU4418789A (en) Synthesis of camptothecin and analogs thereof
GB8618466D0 (en) Administering medicaments to patients
EP0202051A3 (en) Therapeutic compositions for oral administration
HK48592A (en) Treatment of oral diseases
IL108876A0 (en) Pulmonary administration of granulocyte colony stimulating factor
AU2260088A (en) Methods and compositions for the treatment of lung conditions
AU8910891A (en) Treatment of lung diseases
AU577020B2 (en) Improvements relating to the treatment of tobacco
AU3683484A (en) The use of menthol to enhance transdermal drug delivery
SG81391G (en) Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosis
AU9139091A (en) Oral administration of alpha interferon to treat lung malignancies
AU4633893A (en) Liposomal formulations for administering to cancer patients
EP0249165A3 (en) Medicine for combating malignant and chronic diseases
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
NZ231519A (en) 2-cycloalkyl-6-(1-hydroxyethyl)penem derivatives and pharmaceutical compositions
HU9301453D0 (en) Nucleinic acide derivatives of anesthetic effect
AU5381890A (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
AU9132091A (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
AU609435B2 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
AU5350190A (en) Methods and compositions for the identification of patients sensitive to interferon alpha
GB9026620D0 (en) Treatment of lung diseases
AP9000164A0 (en) Improved formulation of law-dose interferon alpha
ZA919959B (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
IT9021051A0 (it) "procedimento di estrzione e purificazione del gamma interferone umano ricombite"